- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Relapsed or Refractory Hematological Malignancies
Total 8575 results
-
Kiromic, Inc.WithdrawnCancer | Hematologic Malignancies
-
Mayo ClinicRecruitingSolid Tumors | Hematologic MalignanciesUnited States
-
Novartis PharmaceuticalsTerminatedSolid Tumor | Hematologic MalignanciesUnited States
-
Teva Branded Pharmaceutical Products R&D, Inc.CompletedSolid Tumors | Hematologic MalignanciesNetherlands
-
Leuko Labs, Inc.M.D. Anderson Cancer Center; Center for Advancing Point of Care Technologies...RecruitingHematologic MalignancyUnited States
-
CRISPR Therapeutics AGEnrolling by invitationHematologic Malignancy | Solid MalignancyUnited States
-
Chinese PLA General HospitalCompletedSolid Tumor | Hematologic MalignancyChina
-
Piramal Enterprises LimitedCompletedSolid Tumor | Hematologic MalignancyIndia
-
ModernaTX, Inc.AstraZenecaActive, not recruitingDose Escalation: Relapsed/Refractory Solid Tumor Malignancies or Lymphoma | Dose Expansion: Triple Negative Breast Cancer, HNSCC, Non-Hodgkins, Urothelial Cancer, Immune Checkpoint Refractory Melanoma, and NSCLC LymphomaUnited States, Israel, Australia
-
Innovent Biologics (Suzhou) Co. Ltd.Recruiting
-
Sorveglianza Epidemiologica Infezioni Fungine Emopatie...CompletedInvasive Fungal InfectionsItaly
-
Calgent Biotechnology Co., LtdCompletedResistant or Refractory Solid TumorsUnited States, Taiwan
-
Curis, Inc.The Leukemia and Lymphoma SocietyCompletedLymphoma | Refractory Lymphoma | Relapsed Lymphoma | Relapsed and/or Refractory Lymphoma | Relapsed Ddiffuse Large B-Cell Lymphoma (DLBCL) | Refractory Diffuse Large B-Cell Lymphoma (DLBCL) | Relapsed and/or Refractory Diffuse Large B-Cell Lymphoma (DLBCL) | Double-hit Lymphoma (DHL) | Triple-hit Lymphoma... and other conditionsUnited States
-
Merck Sharp & Dohme LLCRecruitingSolid Tumors | Hematologic MalignanciesUnited States, Poland, Brazil, Ukraine, Argentina, Australia, Austria, Belgium, Canada, Chile, China, Colombia, Czechia, Denmark, Estonia, Finland, France, Germany, Greece, Guatemala, Hong Kong, Hungary, Israel, Italy, Japan, Korea, Republic... and more
-
A.O. Ospedale Papa Giovanni XXIIIRegional Hospital of Bolzano; Azienda Ospedaliera San Gerardo di MonzaCompleted
-
Azienda Ospedaliera Ospedale Infantile Regina Margherita...Associazione Italiana Ematologia Oncologia PediatricaRecruitingDiagnosed or Relapsed/Refractory SarcomasItaly
-
Tarapeutics Science Inc.RecruitingRelapsed or Refractory Acute Myeloid Leukemia (AML)China
-
Anhui Provincial HospitalNot yet recruitingAcute Graft-versus-host DiseaseChina
-
Istituto Clinico HumanitasCompletedInfection | Graft Vs Host Disease | Hematological Malignancy | Bone Marrow Transplant Complications | Bone Marrow Transplant InfectionItaly
-
Dokuz Eylul UniversityUniversity of LiverpoolUnknownAdverse Drug ReactionsTurkey
-
Maastricht University Medical CenterDirinco B.V.TerminatedThrombosis | Bacteremia | Hematological MalignanciesNetherlands
-
NYU Langone HealthTerminated
-
Assistance Publique - Hôpitaux de ParisNational Cancer Institute, France; Canceropôle Ile de France; Oncogeriatric Coordination... and other collaboratorsRecruiting
-
PfizerTerminatedSolid Tumor | Hematologic MalignanciesUnited States
-
Firas El Chaer, MDRecruitingHematologic Malignancy | Platelet RefractorinessUnited States
-
Dialectic Therapeutics, IncCompletedSolid Tumor | Hematologic MalignancyUnited States
-
Institut de cancérologie Strasbourg EuropeCompletedHematologic Malignancy | Tumor, SolidFrance
-
M.D. Anderson Cancer CenterBTG International Inc.Terminated
-
UNC Lineberger Comprehensive Cancer CenterGenentech, Inc.CompletedHematologic Malignancies | Malignant Solid TumorUnited States
-
Sidney Kimmel Cancer Center at Thomas Jefferson...CompletedHematopoietic/Lymphoid CancerUnited States
-
National Cancer Institute (NCI)Active, not recruitingCutaneous T-Cell Lymphoma | Peripheral T-Cell Lymphoma | Mature T-cell Malignancies | Relapsed/ Refractory T-cell MalignanciesUnited States
-
Tarapeutics Science Inc.RecruitingRelapsed or Refractory Acute Myeloid Leukemia (AML)China
-
Syndax PharmaceuticalsAvailable
-
National Cancer Institute (NCI)RecruitingLymphoma | Non-Hodgkin Lymphoma | NHL | Hematologic Malignancies | Lymphoid MalignanciesUnited States
-
Mount Sinai Hospital, CanadaActive, not recruitingStem Cell Transplant | Hematologic MalignancyCanada
-
Atridia Pty Ltd.CompletedSolid Tumors and Hematologic MalignancyAustralia
-
Incyte CorporationCompletedSolid Tumors and Hematologic MalignancyUnited States
-
BeiGeneCompletedRelapsed or Refractory Chronic Lymphocytic Leukemia | Relapsed or Refractory Small Lymphocytic LymphomaChina
-
Stanford UniversityCompletedLeukemia | Blood CancerUnited States
-
Merck Sharp & Dohme LLCTerminated
-
CASI Pharmaceuticals, Inc.CompletedMyelodysplasia | Hematological Malignancies | Agnogenic Myeloid MetaplasiaCanada
-
Memorial Sloan Kettering Cancer CenterCompletedLymphoma | Acute Myeloid Leukemia | Leukemia | Myelodysplastic Syndrome | Myeloma | Hematological MalignancyUnited States
-
Memorial Sloan Kettering Cancer CenterPharmacyclics LLC.; Janssen Biotech, Inc.RecruitingAdult Patients With Newly Diagnosed or Relapsed or Refractory Primary Central Nervous System Lymphoma (PCNSL) | Or Relapsed or Refractory Secondary Central Nervous System Lymphoma (SCNSL)United States
-
Ciusss de L'Est de l'Île de MontréalUnknownRelapsed Multiple Myeloma | Relapsed Non Hodgkin Lymphoma | Hematologic Cancer | Relapsed Adult AML | Relapse Leukemia | Relapsed Adult ALL | Relapsed CLL | Relapsed Hodgkin's Lymphoma | Relapsed Myelodysplastic SyndromesCanada
-
Nationwide Children's HospitalRecruitingHematologic Malignancy | Hematopoietic Stem Cell TransplantationUnited States
-
Peking University People's HospitalRecruitingHematologic Malignancy | Stem Cell Transplant ComplicationsChina
-
Duke UniversityRecruiting
-
Dana-Farber Cancer InstituteCompletedHematologic MalignancyUnited States
-
Abramson Cancer Center of the University of PennsylvaniaCompletedPatients With Lung, Breast, Head and Neck, or Pelvic MalignanciesUnited States
-
Westlake TherapeuticsRecruitingCancer | Solid Tumor | Hematologic MalignancyChina